Business | Press Trust of India | Tuesday December 6, 2022
Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial.
www.ndtv.com/business